gene therapies, announced today a partnership with Elaaj Bio, a biotechnology company focused on development of transformative treatments for CDKL5 Deficiency Disorder (CDD). Elaaj Bio is a wholly owned subsidiary of the Loulou Foundation, a private...
medications by date and time into convenient packets, then delivers them to customers’ doors at no extra cost. For more information please visit, www.amazon-pharmacy.com
Joi + Blokes, a telehealth platform specializing in diagnostic testing, personalized medicine, and hormone and menopause care, announced the publication of a new peer-reviewed study demonstrating that testosterone replacement therapy (TRT) in...
in New Zealand and Australia (ENABLE-2, NCT06486051) BioOra's automated manufacturing process, utilising the Cocoon ® platform developed by the Octane Medical Group, is a core competitive advantage, enabling more consistent, scalable, and...
company collaborates with leading breast milk and microbiome researchers to bring cutting-edge science to families. Across formulation and manufacturing, NurtureBio applies a research-first standard, including collaboration with academic partners...
2nd Annual MaxPotent Pharma Summit – a leading international platform bringing together senior executives, regulatory authorities, technology providers, and pharmaceutical innovators dedicated to advancing the future of Highly Potent Active...
currently supports clinical trials in at least 18 countries across the Americas, Asia, Australia, and Europe. For more information please visit, www.infocusclinical.com
refractory heart failure due to leaky tricuspid valve (TR). The first stage of the docking device implantation was performed 3 months ago. In recent days, the second stage of fully percutaneous transcatheter heart valve implantation within the...
also at high risk for these events.1 Oral semaglutide for type 2 diabetes has been available as Rybelsus® in a different formulation and set of doses. "Ozempic® has become a leading, trusted brand for people with type 2 diabetes and the science is...
Jakafi XR tablet taken once-daily (QD) is bioequivalent to a single 25 mg Jakafi tablet, the immediate-release (IR) dosage form, taken twice-daily (BID). This means that, based on key measures of steady-state drug exposure, it delivers the same...
indications. The acquisition of Candid builds on UCB’s recently announced transaction with Antengene and reflects a platform-driven strategy in next-generation immunology. Together, these complementary investments expand UCB’s reach across multiple...
Sprout now stands alongside global powerhouses like Novo Nordisk and Genentech, a reflection of both its operating performance and its role in expanding the boundaries of modern healthcare. "We built this company to challenge a system that told...
over-ordering, and allows pharmacies to better match inventory to demand – especially when space is limited. Product Information YARAL Pharma’s Diclofenac Epolamine Topical System 1.3% is a nonsteroidal anti-inflammatory drug (NSAID) and is...
treatment to patients in Europe and other international markets. CE Marking, supported by an EU Declaration of Conformity and independently assessed by a Notified Body, represents SQ Innovation's formal declaration that the Company's Infusor for...
into VA and DoD systems is a meaningful step toward changing that." Rapid Nexus is advancing its broader technology platform, including NerveStim™ and Hemastyl®, through the FDA's breakthrough device designation pathway for chronic wound and...
plaque psoriasis, psoriatic arthritis, Crohn's disease and ulcerative colitis.8,9 U.S. Indications and Important Safety Information about SKYRIZI® (risankizumab-rzaa)8 SKYRIZI is a prescription medicine used to treat adults with: moderate to severe...
areas of pain management, infectious disease, ophthalmology, oncology, respiratory and central nervous system. For more information please visit, www.mundipharma.com
independence in individual patients. We look forward to further evaluating CK0801 as a potentially non-toxic, transformative and curative therapy that can bring meaningful improvements in patient lives" CK0801 is designed to act, in effect, as an...
its proprietary Artificial Intelligence-assisted Structure-Based Drug Discovery (AISBDD) and Ultra-Long-Acting Platform (ULAP) technologies as well as Peptide Oral Transport ENhancement Technology (POTENT), Ascletis has developed multiple drug...
prospective evaluation of TPX-100 as a potential modifier of structural disease progression. These findings also may inform patient stratification strategies in future clinical trials. In addition, they support further evaluation of femoral...
